FindTrial
Sign In

A Clinical study to compare the effects of Effectiveness Of 7.5 Percent Povidone Iodine In Comparison To 1 Percent Clotrimazole In The Treatment Of Otomycosis to patients coming to the ENT OPD at SRM Medical College Hospital And Research Centre

Effectiveness Of 7.5 Percent Povidone Iodine In Comparison To 1 Percent Clotrimazole In The Treatment Of Otomycosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046560
Enrollment
300
Registered
2022-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H60-H95- Diseases of the ear and mastoid process

Interventions

Intervention1: Installation of 7.5 Percent Povidone Iodine : Using 7.5 Percent Povidone Iodine in patients diagnosed to have Otomycosis to compare its Anti-Fungal Effects in comparison to Clotimazole

Sponsors

SRM Medical College Hospital And Reseach Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with either of the symptoms of Itching sensation of the Ear , Ear blocking sensation , Ear pain

Exclusion criteria

Exclusion criteria: Patient Diagnosed to have Chronic Suppurative Otitis Media Post Operative Mastoidectomy Patients Patient diagnosed to have Malignant Otitis Externa Patient on Hearing Aids Patient on Chemotherapy , Radiotherapy or any other state of Immunosupression Patients not willing to take part in study

Design outcomes

Primary

MeasureTime frame
Elimination of disease from the Affected Ear using Otoscopic / Microscopic Direct Visualisation . To Assess the absence of Spores on examination .Timepoint: 2 weeks—

Secondary

MeasureTime frame
Persistence of Otomycotic debris even after line of managementTimepoint: 3 weeks—

Countries

India

Contacts

Public ContactSelvarajan G

SRM Medical College Hospital And Research Center

drselvarajang@gmail.com9442589122

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026